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Summary: Commercially available radioimmunoassay kits for determination of serum cholic and chenodeoxycholic
acid conjugates ("Glycocholic acid RIA kit", "Glycochenodeoxycholic acid RIA kit", Nordiclab Oy, Oulu, Finland)
have been evaluated with respect to recovery, specificity and precision. The recovery of the glycocholic acid method
was low when performed according to the manufacturer's instructions, but could be raised to an acceptable level by
using serum-based standards. However, the non-specific binding of serum samples varied considerably in the glyco-
cholic acid method and would demand the use of individual blanks. The recovery of the glycochenodeoxycholic acid
method was satisfactory and no inter-individual serum effect was discovered. The methods were considered sufficiently
specific for their purposes, but precision was rather low for values within the lower normal range in both methods.
We conclude that the glycochenodeoxycholic acid method is satisfactory for its purpose, but the glycocholic acid
method needs to be modified.
Bestimmung von Cholsäure und Chenodesoxycholsäure im Serum:
Bewertung zweier käuflicher Radio immunassay-Methoden
Zusammenfassung: Käuflich erhältliche Radioimmunassay-Bestecks für die Bestimmung von Cholsäure- und Cheno-
desoxycholsäure-konjugaten im Serum (Glycocholic acid RIA kit, Glycochenodeoxycholic acid RIA kit, Nordiclab
Oy, Oulu, Finnland) wurden hinsichtlich Wiederfindung, Spezifität und Präzision bewertet. Die Wiederfindung mit
der Glykocholsäure-Methode war niedrig, wenn sie nach Angaben des Herstellers ausgeführt wurde, konnte jedoch
bei Verwendung von Standards auf Serumbasis auf einen annehmbaren Wert verbessert werden. Die unspezifische
Bindung durch Serumproben wechselte jedoch beträchtlich bei der Glykocholsäure-Methode und erforderte indi-
viduelle Leerwerte. Die Wiederfindung mit der Glykochenodesoxycholsäure-Methode war zufriedenstellend und
interindividuelle Serum-Effekte konnten nicht festgestellt werden. Die Methoden werden für ihren Zweck als aus-
reichend spezifisch erachtet, jedoch war die Präzision für beide Methoden für Werte im unteren Normalbereich eher
gering. Wir folgern, daß die Glykochenodesoxycholsäure-Methode ihrem Zweck genügt, die Glykocholsäure-Methode
jedoch der Modifikation bedarf.
Introduction of similar radioimmunoassay techniques have been
_. . . ... .j , . . .. u reported (summarized in 1. c. (4)). Recently radio-The interest in serum bile acid determinations has grown . r v i··,, r * · /· r i u r * A., , t , . 4 · . : ; · - , . ,. - unmunoassay kits for determination of glycocholic andconsiderably during recent years and several studies / 7 j - i u r tJ' . .. : r ... ., _ glycochenodeoxycholic acid in serum (Nordiclab Oy,have shown that raised levels of serum bile acids are * J _u v /
sensitive indicators of impaired liver function (1). Fmland> have become available The purpose of this
Furthermore, measurements of postprandial elevations Pai*r ls a Cflticalevaluat'on of these klts'
of serum bile acids have been used for investigating the
enterphepatic circulation of bile acids and have been
proposed as a means of detecting bile acid malabsorp* Material and Methods
tion (2). Since the first radioimmunoassay for deter- ^ adds we?e purchased from Sigma (St> ̂ ^ Mo0 and
mination of conjugated cholic acid in serum was purity was checked by thin layer chromatography (5). Bile
described by Simmonds et al. in 1973 (3), a number acid-free serum was prepared according to Schalm et al. (6).
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Radioimmunoassays
for glycocholic and glycochenodeoxycholic acid
The "Glycocholic acid RIA kit" and the "Glycochenodeoxy-
cholic acid RIA kit" are manufactured by Nordiclab Oy, Oulu,
Finland1). According to the manufacturer antibodies were
raised in rabbits against glycocholic and glycochenodeoxycholic
acid coupled to bovine serum albumin. Tracers were [125IJhis-
taminylcholylglycine and [125I]histaminylchenodeoxycholyl-
glycine. Each kit is supplied with standard solutions of glyco-
cholic or glycochenodeoxycholic acid in ethanol (950 ml/1)
covering the concentration range of 0.15-15 μιηοΐ/l, together
with control sera at two levels of bile acid concentration and
contains materials sufficient for 100 tubes.
Assay procedure
The assays were performed according to the manufacturer's
instructions. In the "Glycocholic acid RIA kit" 100 μΐ of serum
was extracted with 400 μ\ of ethanol (950 ml/1) by vortexing
for one minute. In the "Glycochenodeoxycholic acid RIA kit"
20 μΐ of serum was extracted with 1.00 ml of ethanol (950 ml/1).
After centrifugation 100 μΐ portions of the extracts were trans-
ferred in duplicate to assay tubes. After evaporation the bile
acids were dissolved in 200 μΐ of tracer solution and 200 μΐ of
antibody solution was added. Tubes for measuring the non-
specific binding were prepared by adding 200 μΐ of tracer solu-
tion to empty tubes which were further treated as sample tubes.
The tubes were incubated at + 37 °Cfor 1-2 hours. Separation
of free and antibody-bound antigen was accomplished by adding
500 μΐ of polyethylene glycol solution (Carbowax 6000, final
concentration 165 g/1) containing γ-globulin as a carrier protein.
After centrifugation, radioactivity of the precipitates was
measured for 5 minutes in a 16-channel gamma-counter (Nuclear
Enterprises, Edinburgh, Scotland) giving a counting precision
better than 1%.
Straight line standard curves were obtained by a weighted linear
regression analysis of logit (B - N)/(Bo - N) against the logarithm
of the concentration according to Rodbard (7) (B, antibody-
bound fraction; B0, antibody-bound fraction at zero standard
concentration; N, non-specific bound fraction). The fraction of
BO was 0.62 ± 0.06 (mean ± SD, n = 23) of the total counts
present in the assay.
Certain serum samples were also analyzed by radioimmunoassay
methods for glycocholic and glycochenodeoxycholic acid con-
jugates developed in our own laboratory. These comparison
methods were based essentially on the work ofDemers & Hepner
(8) and Simmonds et al. (3). Tracers were glyco-[3H]cholic or
glyco-(3HJchenodeoxycholic acid. Bile acid standards were
prepared in bile acid-free serum as described by Schalm et al.
(6). Standards or patient sera (the latter diluted 1:5 in phos-
phate buffer 10 mmol/1) were added to assay tubes in 100 μΐ
aliquot s followed by 100 μΐ of radiolabe lied bile acid. Anti-
serum, diluted to a concentration at which a fraction of 0.40
of the tracer was bound in zero standard, was added in 200 μΐ
aliquots and, after incubation for 2-24 hours, antibody^bound
and free bile acids were separated by ammonium sulphate
precipitation. The precipitate was dissolved in distilled water
and radioactivity was determined by liquid scintillation counting.
Standard curves were prepared in the same way as for the Nordic-
lab methods. Within-run precision, as determined from dupli-
cate analysis of 350 serum samples, was 6% (CV) and between-
run precision, determined from 60 repetitive assays of control
sera was 10% (CV) in both methods. The detection limit,
calculated from the standard deviation of samples with Ipw
bile acid concentrations (< 0.25 μπιοΐ/l), was 0^06 μηιοΐ/ΐ in
the two comparison methods. Recovery of glycocholic and
glycochenodeoxycholic acid was 94 ± 5% (mean ± SD) and
89 ± 5 % respectively. The specificity of the antisera of the
comparison methods is shown in table 1.
Tab. 1."Cross reactivity of bile acids with antisera of the com-
parison methods.























1) Nordiclab Oy is represented in the Federal Republic of




Figure 1 shows typical standard curves for the Nordiclab
methods. Both methods had their optimal measuring
range for moderately elevated values of bile acids.
Recovery
Recovery of the "Glycocholic acid RIA kit" was deter-
mined by adding glycocholic acid to eight serum samples
with initial glycocholic acid concentrations ranging from
0.1—1.0 μιηοΙ/1 to raise the concentration by 1 μιηόΐ/ΐ.
The recovery was 49 ± 3% (mean ± SD) when using the
ethanol-based standards supplied with the kit. For many
radioimmunoassays, however, it is necessary that the
standards are prepared in a sample4ike medium. Recovery
was therefore tested using standards prepared in bile
acid-free serum. Figure 2 shows the standard curves
obtained with and without serum addition. The dis-
placement of the serum-based curve reflected mainly
losses in the extraction of the serum-based standards.
The recovery found using serum-based standards was
98 ± 8% and the use of serum-based standards thus
seemed necessary. However, the non-specific binding
of different serum samples varied considerably. In one
analytic run the counts of the non-specific binding
varied in 14 different serum samples between 5390—
9170 counts/rnin. It may be calculated that if a sample
contained 0.8 μπιοΐ/ΐ of glycocholic acid (medical
decision limit) this variation of the non-specific binding
would produce results varying between 0.4—1.4 μτηοΙ/1.
Recovery of the "Glycochenodeoxycholic acid RIA
kit" was tested in the same way as described above. The
recovery found was 90 ± 10% (mean ± SD). The method
was tested using ethanol-based standards as well as
serum-based standards, but no significant difference
was detected between the curves prepared with and
without the addition of serum. In the further experi-
ments with the "Glycoehenodeoxyeholic acid RJA kit",
however, we used standards prepared in bile acid-free
serum. No interindividual variation of the non-specific
binding of serum samples was detected in this,method.
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Fig. 1. Typical standard curves produced by the "Glychocholic acid RIA kit" (a) and by the "Glycochenodeoxycholic acid RIA kit"
(b) using ethanol-based standards. B = antibody-bound fraction BQ = antibody-bound fraction at zero standard concentration














Tab. 2. Cross reactivity of bile acids with antisera of the glyco-
cholic and glycochenodeoxycholic acid RIA kits.
0.15 0.25 OS 1 1 2 4 8 15
Glycocholic acid [ju.mol/1]
Fig. 2. Standard curves of the "Glycocholic acid RIA kit":
(· — ·) was obtained by using serum-based standards and
(o — o) was obtained by using the standards supplied with
the kit. B - antibody-bound fraction BO = antibody^
bound fraction at zero standard concentration N = non-
specific bound fraction measured by omitting the anti-
body from the respective zero standard tubes.
Specificity
Cross-reactivity was calculated at 50% displacement of
label (9) and figures are given in table 2. The antiserum
to glycochoUc acid cross-reacted only to a small extent
with unconj g ted and conjugated chenodeoxycholic
acid and exhibited a higher sensitivity to tauririe^con-
jugated cholic acid than to glycine-conjugated cholic
acid. The antiserum to glycochenodeoxycholic acid had
Bile acid Cross reactivity (%)
"Glycocholic "Glycocheno-
acid deoxycholic



















Within parenthesis are the figures given by the manufacturer.
Cross reactivity was determined using one batch of antiserum
for each of the two kits.
almost the same sensitivity to the two conjugates of
chenodeoxycholic acid, but a lower sensitivity to un-
conjugated chenodeoxycholic acid and a low sensitivity
to cholic acid and its conjugates.
Precision
Figures for within-run precision were determined from
duplicate determinations of serum samples and are
shown in table 3. For both methods precision was
acceptable for values in the upper normal range and for
elevated values, but rather low for values within the
lower normal range. As calculated from the standard
deviation of samples with low bile acid concentrations
(< 0.5 Mmol/l),the detection limit was 0.10 μηιοΐ/ΐ in
the "Glycocholic acid RIA kit" and 0.08 μηιοΐ/ΐ in the
"Glycochenodeoxycholic acid RIA kit".
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Tab. 3. Within-run precision of the Nordiclab methods determined from duplicate determinations.





































Reference values were established using sera from 57
healthy fasting individuals, age range 18-71 years,
median age 25 years. Using ethanol-based standards
65% of these sera had values less than zero in the glyco-
cholic acid method, i. e. the bound fraction was greater
than that of the zero standard. The mean and SD for
glycocholic acid were 0.04 and 0.08 μτηοΐ/l respectively,
but using serum-based standards the corresponding values
were 0.33 and 0.21 jumol/l. As calculated from mean +
2 SD the upper reference value using serum-based
standards was 0.8 μπιοΐ/ΐ, i. e. the same value as stated
by the manufacturer. The mean and SD for glycocheno-
deoxycholic acid were 0.66 and 0.39 /zmol/1 respectively
and the upper reference value, as calculated above,
was 1.4 μηιοΐ/ΐ. The manufacturer stated an upper
reference limit of 1.0 μτηοΐ/l for glycochenodeoxycholic
acid.
Correlation
Ninety sera with different glycocholic acid concentra-
tions were analyzed and the correlation between values
obtained by our comparison method and by the Nordic-
lab method using serum-based standards is shown in
figure 3. The Nordiclab method gave significantly higher
results, the slope of the regression line (1.23) being
significantly different from 1 (p < 0.001). The intercept
(0.006) was not significantly different from 0.
For glycochenodeoxycholic acid 90 different serum
samples were analyzed and figure 4 depicts the correla-
tion between values obtained by our comparison method
and by the "Glycochenodeoxycholic acid RIA kit". The
commercial method gave significantly higher values
than our comparison method as the slope (1.27) was
significantly different from 1 (p < 0.001). The intercept
(- 0.038) was not significantly different from 0.
Discussion
In the Nordiclab methods a composite sum of con-
jugated and unconjugated cholic and chenodeoxycholic
acid is measured. In fasting normal subjects serum bile
acid concentrations are low and approximately 50%
(10) are conjugated with either glycine or taurine. The
ratio of glycine-conjugates to taurine-conjugates is about
2:1 to 3:1. Thus, it may be calculated that in normal
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Fig. 3. Comparison of results for serum analysis of glycocholic
acid (GCA) obtained with the "Glycocholic acid RIA
kit" (Nordiclab method) and the radioimmunoassay
method for glycocholic acid developed in our laboratory
(comparison method).
The relation found was:
GCAjfsiordiclab method = 1-23 X GCAcomparison method
+ 0.006
Correlation coefficient 0.96
acid RIA kit" will be approximately 200% of the actual
concentration of glycinerconjugated cholic acid and
about 150% of the true concentrations of the two
conjugates of cholic acid. The "Glycochenodeoxycholic
acid RIA kit" produces results that are about 150% of
the real concentration of glycine-conjugated cheno-
deoxycholic acid and approximately 120% of the
actual concentrations of taurine- plus glycine-conjugated
chenodeoxycholic acid in these sera. In patients with
liver disease serum bile acids may be grossly elevated, up
to 100 times the normal concentration or more, and
this increase consists largely of conjugated .bile acids. In
these sera the ratio of glycine-conjugated to taurine-
conjugated bile acids is usually lower than in normal
sera. Values obtained with the "Glycocholic acid RIA
kit" in these sera will be about 300% of the true con-
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Fig. 4. Comparison of results for serum analysis of glycochenode-
oxycholic acid (GCD) obtained with the "Glycocheno-
deoxycholic acid RIA kit" (Nordiclab method) and the
radioimmunoassay method for glycochenodeoxy cholic
acid developed in our laboratory (comparison method).
The relation found was
GCDNor(jiciab method 1-27 X
-0.038
Correlation coefficient = 0.96
method
centration of glycine-conjugated cholic acid and
approximately 140% of the actual concentration of
the two conjugates of cholic acid. The "Glycocheno-
deoxycholic acid RIA kit" will produce values about
200% of the true concentration of glycine-conjugated
chenodeoxycholic acid in these pathological sera.
ever, these values will be close to the true concentra-
tions of conjugates of chenodeoxycholic acid (95-
100%).
The Nordiclab kits are provided with a bile acid standard
prepared in ethanol. Our investigations clearly show
that the glycocholic acid method should be supplied
with serum-based standards to produce more accurate
results. However, the interindividual variation of the
nonspecific binding of serum samples demands further
development of the method, e. g. raising the analytical
sensitivity of the method to allow higher sample dilu-
tion. The glycochenodeoxycholic acid method has a
higher analytical sensitivity than the glycocholic acid
method. This allows higher sample dilution and there-
fore the use of serum-based standards does not seem
necessary.
In both Nordiclab methods only sera with substantially
raised bile acid concentrations need to be diluted. This
advantage is, however, balanced by less precise measure-
ments of values within the normal range. Accurate
determinations of postprandial elevations of serum
bile acids can therefore hardly be obtained.
Raised levels of serum bile acids are considered a
sensitive indicator of impaired liver function. The two
primary bile acids, cholic and chenodeoxycholic acid,
can be determined separately by radioimmunoassay,
since the cross-reactivity between these bile acids are
usually less than 10%. This is of clinical importance,
as in cholestatic liver disorders, cholic acid is the major
bile acid found in serum, whereas in alcoholic liver
disease and cirrhosis a predominance of chenodeoxy-
cholic acid in serum is usually found (11,12, 13).
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